Potentiated β-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice

European Journal of Pharmacology

Volumn 350, Issue 2-3, 1998, Pages 243-250

  Simonsson, Erik ^a   Ahrén, Bo ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

2 Deoxyglucose; Acetylcholine receptor; Cholecystokinin; Cholinergic agonism; GLP 1; Insulin resistance; Insulin secretion; Type 2 diabetes

Indexed keywords

CARBACHOL; CHOLECYSTOKININ; CHOLINERGIC RECEPTOR; DEOXYGLUCOSE; GLUCAGON LIKE PEPTIDE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES; BLOOD GLUCOSE; BODY WEIGHT; CARBACHOL; DEOXYGLUCOSE; DIET; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MUSCARINIC AGONISTS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; SINCALIDE; STIMULATION, CHEMICAL;

EID: 0032486135     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00236-2     Document Type: Article

References (40)

1. Ahrén B. Insulinotropic action of truncated glucagon-like peptide-1 in mice. Acta Physiol. Scand. 153:1995;205-206.
2. Ahrén, B., 1996. The endocrine pancreas. In: Jensen, S.L., Gregersen, H., Moody, F., Shokouh-Amiri, M.H. (Eds.), Essential of Experimental Surgery: Gastroenterology and Endocrinology. Harwood Academic, Chur, pp. 43/1-43/18.
3. Ahrén, B., 1998. Glucagon-like peptide 1 (GLP-1) - a gut hormone of potential interest in the treatment of diabetes. BioEssays, in press.
4. Ahrén B., Lundquist I. Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion. Acta Diabetol. 18:1981;345-356.
5. Ahrén B., Lundquist I. Modulation of basal insulin secretion in the obese, hyperglycemic mouse. Metabolism. 31:1982;172-179.
6. Ahrén, B., Karlsson, S., Lindskog, S., 1990. Cholinergic regulation of the endocrine pancreas. In: Aquilonius, S., Gillberg, P.G. (Eds.), Progress in Brain Research, Vol. 84, Cholinergic Neurotransmission. Elsevier, Amsterdam, pp. 209-218.
7. Ahrén B., Karlsson S., Scheurink A.J.W., Steffens A.B. Involvement of nitric oxide in neuroglycopenia-induced insulin and glucagon secretion in the mouse. Eur. J. Pharmacol. 280:1995;27-35.
8. Ahrén B., Sundkvist G., Mulder H., Sundler F. Blockade of muscarinic transmission increases the frequency of diabetes after low-dose alloxan challenge in the mouse. Diabetologia. 39:1996;383-390.
9. Ahrén B., Simonsson E., Scheurink A.J.W., Mulder H., Myrsén U., Sundler F. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism. 46:1997;97-106.
10. Ahrén B., Månsson S., Gingerich R.L., Havel P.J. Regulation of plasma leptin in mice: influence of age, high-fat diet and fasting. Am. J. Physiol. 273:1997;R113-R120.
11. Bergman R.N., Phillips L.S., Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J. Clin. Invest. 68:1981;1456-1467.
12. Chan C.B., Pederson R.A., Buchan A.M.J., Tubesing K.B., Brown J.C. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat. Diabetes. 33:1984;536-542.
13. Chen N.G., Romsos D. Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion. Endocrinology. 136:1995;505-511.
14. Corkey B.E., Glennon M.G., Chen K.S., Deeney J.T., Matschinsky F.M., Prentki M. A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic β-cells. J. Biol. Chem. 264:1989;21608-21612.
15. Cramer F.B., Woodward G.E. 2-Deoxy-D-glucose as an antagonist of glucose in yeast fermentation. J. Franklin. Inst. 253:1979;354-360.
16. DelRio G., Procopio M., Bondi M., Marrama P., Menozzi R., Oleandri S.E., Grottoli S., Maccario M., Velardo A., Ghigo E. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int. J. Obes. 21:1997;1111-1114.
17. Emilsson V., Liu Y.L., Cawthorne M.A., Morton N.M., Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes. 46:1997;313-316.
18. Fehmann H.C., Göke R., Göke B. Cellular and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide. Endocr. Rev. 16:1995;390-410.
19. Filipsson, K., Pacini, G., Scheurink, A.J.W., Ahrén, B., 1998. Pituitary adenylate cyclase activating polypeptide stimulates insulin secretion but inhibits insulin sensitivity in mice. Am. J. Physiol., in press.
20. (7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse. Pancreas. 6:1991;208-215.
21. (-7-37) in vivo during short- or long-term administration. Metabolism. 44:1995;1231-1237.
22. Kahn S.E., Prigeon R.L., McCulloch D.K., Boyko E.J., Bergman R.N., Schwartz M.W., Neifing J.L., Ward W.K., Beard J.C., Palmer J.P., Porte D. Jr. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function. Diabetes. 42:1993;1663-1672.
23. Kaku K., Fiedorek F.T., Province M., Permutt M.A. Genetic analysis of glucose tolerance in inbred mouse strains. Diabetes. 37:1988;707-713.
24. Karlsson S., Ahrén B. Inhibition of 2-deoxy-glucose-induced glucagon secretion by muscarinic and α-adrenoceptor blockade in the mouse. Diabetes Res. Clin. Pract. 3:1987;239-242.
25. Karlsson S., Ahrén B. Cholecystokinin and the regulation of insulin secretion. Scand. J. Gatroenterol. 27:1992;161-165.
26. Karlsson S., Ahrén B. Muscarinic receptor subtypes in carbachol-stimulated insulin and glucagon secretion in the mouse. J. Auton. Pharmacol. 13:1993;439-446.
27. Karlsson S., Bood M., Ahrén B. The mechanism of 2-deoxy-glucose-induced insulin secretion in mouse. J. Auton. Pharmacol. 7:1987;135-144.
28. Larsson H., Ahrén B. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia. 39:1996;1099-1107.
29. Lee S.K., Opara E.C., Surwit R.S., Feinglos M.N., Akwari O.E. Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas. 11:1995;206-211.
30. Malm D., Giaever A., Vonen B., Florholmen J. Cholecystokinin and somatostatin modulate the glucose-induced insulin secretion by different mechanisms in pancreatic islets: a study on phosholipase C activity and calcium requirement. Scand. J. Clin. Lab. Invest. 53:1993;671-676.
31. Okabayashi Y., Otsuki M., Ohki A., Tani S., Baba S. Increased β-cell secretory responsiveness to ceruletide and TPA in streptozotocin-induced mildly diabetic rats. Diabetes. 38:1989;1042-1047.
32. Östenson C.G., Grill V. Evidence that hyperglycaemia increases muscarinic binding in pancreatic islets of the rat. Endocrinology. 121:1987;1705-1710.
33. Parmar N.S., Tariq M., Ageel A.M. Proglumide, a cholecystokinin receptor antagonist, exacerbates alloxan-induced diabetes mellitus in Swiss mice. J. Pharm. Pharmacol. 39:1987;1028-1030.
34. Polonsky K.S., Given B.D., Hirsch L.J., Tillil H., Shapiro E.T., Beebe C., Frank B.H., Galloway J.A., van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. New Engl. J. Med. 318:1988;1231-1239.
35. Porte D. Jr. β-cells in type 2 diabetes mellitus. Diabetes. 40:1991;166-180.
36. Rohner-Jeanrenaud F., Hochstrasser A.C., Jeanrenaud B. Hyperinsulinemia of preobese and obese fa/fa rats is partly vagus nerve mediated. Am. J. Physiol. 244:1983;E317-E322.
37. Sako Y., Grill V.E. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology. 127:1990;1580-1589.
38. Simonsson E., Karlsson S., Ahrén B. Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion. Regul. Pept. 65:1996;101-107.
39. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes. 37:1988;1163-1167.
40. Tanizawa Y., Okuya S., Ishihara H., Asano T., Yada T., Oka Y. Direct stimulation of basal insulin secretion by physiological concentrations of leptin in pancreatic cells. Endocrinology. 138:1997;4513-4516.